Welcome to an InDex Pharmaceuticals business update presentation in Stockholm on May 9, from 13:00 to 15.30 CET
April 26, 2023 – InDex Pharmaceuticals Holding AB (publ) invites investors, analysts and media to attend a live business update during which Jenny Sundqvist, CEO, and the InDex Pharmaceuticals leadership team will share insights and updates on the company's mission to improve the lives of patients suffering from immunological diseases. Focus will be on the ongoing phase III program CONCLUDE with the company's lead asset, cobitolimod - a potential new medication for patients with ulcerative colitis.The event will take place at the Redeye offices on Mäster Samuelsgatan 42 (10th floor) in